|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hyperglycemia, Insulin Resistance, Impaired Pancreatic β-Cell Function, and Risk of Pancreatic Cancer显示文摘 | Brian M. Wolpin Ying Bao Zhi Rong Qian Chen Wu Peter Kraft Shuji Ogino Meir J. Stampfer Kaori Sato Jing Ma Julie E. Buring Howard D. Sesso I-Min Lee John Michael Gaziano Anne McTiernan Lawrence S. Phillips Barbara B. Cochrane Michael N. Pollak JoAnn E. Ma | 2013 | JNCI Journal of the National Cancer Institute2013，，14： | 2 |
| 2 | Plasma folate, vitamin B6, vitamin B12, and homo- cysteine and pancreatic cancer risk in four large cohorts显示文摘 | Schernhammer E Wolpin B Rifai N Cochrane B Manson J A Ma J | 2007 | Cancer Res2007，67，： | 1 |
| 3 | Hyperglycemia,insulin resistance,impaired pancreatic β-cell function,and risk of pancreatic cancer显示文摘 | Wolpin BM Bao Y Qian ZR | 2013 | J Natl Cancer Inst2013，105，14： | 1 |
| 4 | Adjuvant treatment of colorectal cancer显示文摘 | Wolpin BM Meyerhardt JA Mamon HJ | | 0，，： | 1 |
| 5 | Circulation insulin-like growth factor binding protein-1 and the risk of pancreatic cancer显示文摘 | Wolpin BM Michaud DS Giovannucci EL | | 0，，16： | 1 |
| 6 | Adjuvant treatment ofcolorectal cancer显示文摘 | Wolpin BM Meyerhardt JA Mamon HJ | 2007 | CA Cancer J Clin2007，57，3： | 1 |
| 7 | Systemic treatment of colorectal cancer 显示文摘 | Wolpin B M Mayer R J | 2008 | Gastroenterology2008，134，5： | 1 |
| 8 | Systemic treatment of colorectal cancer显示文摘 | Wolpin B M Mayer R J | 2008 | Gastroenterology2008，134，5： | 1 |
| 9 | Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer显示文摘 | Wolpin BM Hezel AF Abrams T | 2009 | J Clin Oncol2009，27，2： | 1 |
| 10 | The solution and estimation of discrete choice dynamic programming models by simulation:Monte carla evidence显示文摘 | Keare M Wolpin K | 1994 | Review of Economics and Statistics1994，，76： | 1 |
| 11 | ABO blood group and incidence of epithelial ovarian cancer 显示文摘 | Gates MA Wolpin BM Cramer DW | 2011 | Int J Cancer2011，128，2： | 1 |
| 12 | Adjuvanttreatment of colorectal cancer显示文摘 | Wolpin B M Meyerhardt J A Mamon H J | 2007 | CA Cancer J Clin2007，57，3： | 1 |
| 13 | Hyperglycemia, Insulin Resistance, Impaired Pancreatic β-Cell Function, and Risk of Pancreatic Cancer显示文摘 | Brian M. Wolpin Ying Bao Zhi Rong Qian Chen Wu Peter Kraft Shuji Ogino Meir J. Stampfer Kaori Sato Jing Ma Julie E. Buring Howard D. Sesso I-Min Lee John Michael Gaziano Anne McTiernan Lawrence S. Phillips Barbara B. Cochrane Michael N. Pollak JoAnn E. Ma | 2013 | JNCI Journal of the National Cancer Institute2013，，14： | 1 |
| 14 | ABO blood group and incidence of epithelial ovarian cancer显示文摘 | Gates MA Wolpin BM Cramer DW | 2011 | Int J Cancer2011，128，： | 1 |
| 15 | Systemic treatment of colorectal cancer 显示文摘 | Wolpin BM Mayer RJ | 2008 | Gastroenterology2008，134，： | 1 |
| 16 | Adjuvant treat?ment of colorectal cancer显示文摘 | Wolpin BM Meyerhardt JA Mamon HJ | 2007 | CA Cancer J Clin2007，57，3： | 1 |
| 17 | The safety of IPI-926, a novel hedgehog pathway inhibitor, in combi- nation with gemcitabine in patients (pts) with metastatic pancre- atic cancer 显示文摘 | STEPHENSON J RICHARDS DA WOLPIN BM | 2011 | J Clin Oncol2011，，： | 1 |
| 18 | A phase lb trial of IPI-926, a hedgehog pathway inhibitor, plus gemcit- abine in patients with metastatic pancreatic cancer 显示文摘 | RICHARDS DA STEPHENSON J WOLPIN BM | 2012 | J Clin Oncol2012，30，4： | 1 |
| 19 | ABO blood group and risk of coronary heart disease in two prospective cohort studies显示文摘 | He M Wolpin B Rexrode K Manson J E Rimm E Hu F B | 2012 | Arterioscler Thromb Vasc Biol2012，32，： | 1 |
| 20 | Inlerseetoral Labor Mobility and the Growth of the Service Sector 显示文摘 | Lee D Wolpin K | 2006 | Econometrica2006，47，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员